Key CCNFSDU45 Outcomes: Codex Moves Forward on Infant Formula
The 45th session of the Codex Committee on Nutrition and Foods for Special Dietary Uses (CCNFSDU) reached several conclusions relevant to infant formula, particularly regarding food additives, analytical methods and microbiological safety.
The Committee concluded that lactic acid (INS 270), lecithin (INS 322(i)), citric acid and citrates (INS 330, 331(i), 331(iii), 332(i) and 332(ii)), and mono- and diglycerides of fatty acids (INS 471) are technologically justified for use in products covered by the Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants(CXS 72-1981), subject to the specified conditions. Conversely, basic methacrylate copolymer (BMC; INS 1205) was considered not technologically justified.
The relevant recommendations will be forwarded to CCFA for further consideration. The work on additives will continue and for this an electronic working group will assess the technological justification for hydroxides (INS 524, 525 and 526), carbonates (INS 500 and 501), carbon dioxide (INS 290) and nitrogen (INS 941), provided applicants supply information on use and use levels and commit to providing safety data for infants below 12 weeks of age.
CCNFSDU also agreed to retain the existing nitrogen-to-protein conversion factors and Type II and III analytical methods for infant and follow-up formula, highlighting the importance of reliable compositional verification for this vulnerable population.
Finally, microbiological safety remains an important area to monitor. JEMRA has begun further work on hazards in powdered infant formula, while CCFH is expected to consider revising the Codex hygienic practice code for powdered formula, potentially addressing spore-forming bacteria not currently covered.
It becomes relevant to particularly monitor the forthcoming CCFA consideration of additive provisions and the next phase of Codex work on additives and microbiological hazards, as these could ultimately affect formulation, supporting safety data, analytical compliance and microbiological controls for infant formula.
